HK1154000A1 - Asymmetric process for making substituted 2-amino-thiazolones - Google Patents

Asymmetric process for making substituted 2-amino-thiazolones

Info

Publication number
HK1154000A1
HK1154000A1 HK11108255.0A HK11108255A HK1154000A1 HK 1154000 A1 HK1154000 A1 HK 1154000A1 HK 11108255 A HK11108255 A HK 11108255A HK 1154000 A1 HK1154000 A1 HK 1154000A1
Authority
HK
Hong Kong
Prior art keywords
thiazolones
amino
making substituted
asymmetric process
compounds
Prior art date
Application number
HK11108255.0A
Other languages
English (en)
Inventor
Seb Caille
Sheng Cui
Xiang Wang
Margaret Faul
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of HK1154000A1 publication Critical patent/HK1154000A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK11108255.0A 2008-07-29 2011-08-08 Asymmetric process for making substituted 2-amino-thiazolones HK1154000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8454908P 2008-07-29 2008-07-29
PCT/US2009/051929 WO2010014586A1 (en) 2008-07-29 2009-07-28 Asymmetric process for making substituted 2-amino-thiazolones

Publications (1)

Publication Number Publication Date
HK1154000A1 true HK1154000A1 (en) 2012-04-13

Family

ID=41020998

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11108255.0A HK1154000A1 (en) 2008-07-29 2011-08-08 Asymmetric process for making substituted 2-amino-thiazolones

Country Status (21)

Country Link
US (2) US8501954B2 (xx)
EP (1) EP2321290B1 (xx)
JP (1) JP2011529896A (xx)
KR (1) KR20110048520A (xx)
CN (1) CN102112454B (xx)
AU (1) AU2009276757A1 (xx)
BR (1) BRPI0916270A2 (xx)
CA (1) CA2730711A1 (xx)
CL (1) CL2011000120A1 (xx)
CY (1) CY1113135T1 (xx)
DK (1) DK2321290T3 (xx)
EA (1) EA019573B1 (xx)
ES (1) ES2386613T3 (xx)
HK (1) HK1154000A1 (xx)
IL (1) IL210562A (xx)
MX (1) MX2011001009A (xx)
PL (1) PL2321290T3 (xx)
PT (1) PT2321290E (xx)
SI (1) SI2321290T1 (xx)
WO (1) WO2010014586A1 (xx)
ZA (1) ZA201100358B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853420B2 (en) 2008-07-29 2014-10-07 Boehringer Ingelheim International Gmbh Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116002A2 (en) * 2004-05-24 2005-12-08 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
JP5204662B2 (ja) 2005-11-22 2013-06-05 アムジエン・インコーポレーテツド １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
AU2006317070B2 (en) * 2005-11-22 2011-06-23 Amgen, Inc. Catalyzed process of making C-5-substituted heterocyclic inhibitors of 11beta-hydroxy steroid dehydrogenase type 1
US8541593B2 (en) * 2007-06-21 2013-09-24 Amgen Inc. Process for making substituted 2-amino-thiazolones

Also Published As

Publication number Publication date
WO2010014586A1 (en) 2010-02-04
EP2321290A1 (en) 2011-05-18
IL210562A (en) 2013-11-28
US20130345432A1 (en) 2013-12-26
BRPI0916270A2 (pt) 2018-10-16
US20110178307A1 (en) 2011-07-21
CL2011000120A1 (es) 2011-06-24
PT2321290E (pt) 2012-08-10
IL210562A0 (en) 2011-03-31
AU2009276757A1 (en) 2010-02-04
ZA201100358B (en) 2011-10-26
PL2321290T3 (pl) 2012-11-30
EA019573B1 (ru) 2014-04-30
MX2011001009A (es) 2011-04-27
JP2011529896A (ja) 2011-12-15
US8501954B2 (en) 2013-08-06
CN102112454A (zh) 2011-06-29
CA2730711A1 (en) 2010-02-04
CY1113135T1 (el) 2016-04-13
SI2321290T1 (sl) 2012-09-28
CN102112454B (zh) 2013-09-04
EA201170072A1 (ru) 2011-08-30
EP2321290B1 (en) 2012-06-20
KR20110048520A (ko) 2011-05-11
ES2386613T3 (es) 2012-08-23
DK2321290T3 (da) 2012-07-16

Similar Documents

Publication Publication Date Title
SG170729A1 (en) Processes and intermediates for preparing steric compounds
MY148253A (en) Azaadamantane derivatives and methods of use
MY150596A (en) Hsp90 inhibitors
WO2009005647A3 (en) Compounds and process to prepare chiral intermediates for synthesis of paroxetine
WO2008151170A3 (en) Process for the synthesis of ramelteon and its intermediates
MY150542A (en) Cmet inhibitors
HK1152712A1 (en) Compounds including an anti-inflammatory pharmacore and methods of use
UA110197C2 (ru) Соединения, эффективные как ингибиторы для ксантиноксидазы, процесса получения таких соединений и фармацевтической композиции, содержащей терапевтически эффективное количество таких соединений.
PT2470546E (pt) Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor
HK1126777A1 (en) A new process for the synthesis of 2-aminoxazole compounds
MX2009007695A (es) Compuestos complejos de carbohidrato de hierro.
MX2010005530A (es) Activadores de receptor de vitamina d nuevos y metodos de elaboracion de los mismos.
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
WO2010028122A8 (en) Process for making bivalirudin
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
MX2019003639A (es) Proceso enzimatico para obtener 17 alfa-monoesteres de cortexolona y/o sus 9,11-dehidroderivados.
TW200720243A (en) Process for stably operating a continuous preparation process for obtaining acrolein or acrylic acid or a mixture thereof from propane
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
MX347218B (es) Metodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
MX2010009931A (es) Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles.
WO2009039362A3 (en) Chiral synthesis of diazepinoquinolines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160728